This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bentley-Hibbert, S. I.
Right arrow Articles by Godfrey, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bentley-Hibbert, S. I.
Right arrow Articles by Godfrey, H. P.

 Previous Article  |  Next Article 

Infection and Immunity, February 1999, p. 581-588, Vol. 67, No. 2
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Pathophysiology of Antigen 85 in Patients with Active Tuberculosis: Antigen 85 Circulates as Complexes with Fibronectin and Immunoglobulin G

Stuart I. Bentley-Hibbert,1 Xin Quan,1 Thomas Newman,2 Kris Huygen,3 and Henry P. Godfrey1,*

Departments of Pathology1 and Medicine,2 New York Medical College, Valhalla, New York 10595, and Pasteur Institute of Brussels, B-1180 Brussels, Belgium3

Received 20 July 1998/Returned for modification 3 September 1998/Accepted 10 November 1998

Antigen 85 (Ag85) complex proteins are major secretory products of Mycobacterium tuberculosis and induce strong cellular and humoral immune responses in infected experimental animals and human beings. We have previously shown that nanogram doses of these 30- to 32-kDa fibronectin-binding proteins inhibit local expression of delayed hypersensitivity by a T-cell fibronectin-dependent mechanism. Circulating levels of Ag85 might be expected to be elevated in patients with active tuberculosis and possibly to play a role in systemic anergy in these patients. To test this hypothesis, Ag85 was measured in serum and urine by a monoclonal antibody-based dot immunobinding assay in 56 patients and controls with known skin test reactivity. Median serum Ag85 levels were 50- to 150-fold higher in patients with active tuberculosis than in patients with active M. avium-intracellulare disease or other nontuberculous pulmonary disease or in healthy controls (P < 0.001). The median and range of serum Ag85 in patients with active tuberculosis was not significantly different between skin test-positive and -negative subjects. Patients with active M. avium disease could be distinguished from those with disease due to M. tuberculosis by monoclonal anti-Ag85 antibodies of appropriate specificities. No increases in urinary Ag85 were detected in any patient, regardless of the Ag85 level in serum. Chromatographic analysis and immunoprecipitation studies of serum revealed that Ag85 existed in the serum of these patients complexed to either fibronectin or immunoglobulin G (IgG). Uncomplexed circulating Ag85 was demonstrable in serum from fewer than 20% of patients with active tuberculosis. In patients with active tuberculosis, Ag85 is therefore likely to circulate primarily as complexes with plasma fibronectin and IgG rather than in unbound form. The existence of Ag85 complexes with plasma proteins would account for its lack of urinary clearance.

* Corresponding author. Mailing address: Department of Pathology, Basic Science Building, New York Medical College, Valhalla, NY 10595. Phone: (914) 594-4160. Fax: (914) 594-4163. E-mail: hgodfrey{at}nymc.edu.

Infection and Immunity, February 1999, p. 581-588, Vol. 67, No. 2
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Hall-Stoodley, L., Watts, G., Crowther, J. E., Balagopal, A., Torrelles, J. B., Robison-Cox, J., Bargatze, R. F., Harmsen, A. G., Crouch, E. C., Schlesinger, L. S. (2006). Mycobacterium tuberculosis Binding to Human Surfactant Proteins A and D, Fibronectin, and Small Airway Epithelial Cells under Shear Conditions.. Infect. Immun. 74: 3587-3596 [Abstract] [Full Text]  
  • Zuniga, J., Lillo, L., Shin, J. J., Machavarapu, R. L., Quiroga, T., Goycoolea, M., Matsuhiro, B., Aron-Hott, L., Godfrey, H. P., Cabello, F. C. (2005). Salmonella enterica Serovar Typhi O:1,9,12 Polysaccharide-Protein Conjugate as a Diagnostic Tool for Typhoid Fever. J. Clin. Microbiol. 43: 4545-4550 [Abstract] [Full Text]  
  • Fend, R., Geddes, R., Lesellier, S., Vordermeier, H.-M., Corner, L. A. L., Gormley, E., Costello, E., Hewinson, R. G., Marlin, D. J., Woodman, A. C., Chambers, M. A. (2005). Use of an Electronic Nose To Diagnose Mycobacterium bovis Infection in Badgers and Cattle. J. Clin. Microbiol. 43: 1745-1751 [Abstract] [Full Text]  
  • Landowski, C. P., Godfrey, H. P., Bentley-Hibbert, S. I., Liu, X., Huang, Z., Sepulveda, R., Huygen, K., Gennaro, M. L., Moy, F. H., Lesley, S. A., Haak-Frendscho, M. (2001). Combinatorial Use of Antibodies to Secreted Mycobacterial Proteins in a Host Immune System-Independent Test for Tuberculosis. J. Clin. Microbiol. 39: 2418-2424 [Abstract] [Full Text]  
  • Lefevre, P., Denis, O., De Wit, L., Tanghe, A., Vandenbussche, P., Content, J., Huygen, K. (2000). Cloning of the Gene Encoding a 22-Kilodalton Cell Surface Antigen of Mycobacterium bovis BCG and Analysis of Its Potential for DNA Vaccination against Tuberculosis. Infect. Immun. 68: 1040-1047 [Abstract] [Full Text]  
  • Lim, J.-H., Park, J.-K., Jo, E.-K., Song, C.-H., Min, D., Song, Y.-J., Kim, H.-J. (1999). Purification and Immunoreactivity of Three Components from the 30/32-Kilodalton Antigen 85 Complex in Mycobacterium tuberculosis. Infect. Immun. 67: 6187-6190 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»